GlassScriptPhysician profile
Shayibu Harruna
NPI 1134449192
$2,824.14
in general payments reported to CMS, 2019-2025
25 companies · $689 in 2025
The $689 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $155 · 2021: $182 · 2022: $331 · 2023: $464 · 2024: $442 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $559.53 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $439.91 | 2019-2025 | |
| Cardiva Medical, INC. | $248.63 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Amgen INC. | $239.92 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $170.21 | 2019-2020 | |
| Pfizer INC. | $164.60 | 2022-2025 | |
| Abiomed | $133.89 | 2019-2025 | |
| Boston Scientific Corporation | $99.99 | 2022-2024 | Avvigo Guidance System |
| Penumbra, INC. | $84.27 | 2025 | Indigo System |
| Abbott Laboratories | $75.84 | 2024-2025 | Confirm Rx, Aveir, Cardiomems |
| Shockwave Medical, INC | $75.30 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $75.24 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $70.22 | 2020-2025 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $65.64 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $64.19 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $61.79 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Irhythm Technologies, INC. | $33.37 | 2022-2023 | Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.66 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $26.10 | 2019 | |
| Angiodynamics, INC. | $25.07 | 2022 | |
| Philips North America LLC | $18.84 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Astrazeneca Pharmaceuticals LP | $17.70 | 2023 | |
| Vital Connect, INC | $17.64 | 2025 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $17.59 | 2024 | Verquvo |
| Bardy Diagnostics, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shayibu Harruna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.